Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Novartis AGNVS22.294.605.3613.2521.50%14.13%55.79$113.73$595.0257,893$110.56

Detail of Novartis AG

 
Employees
76057
Industry
Drug Manufacturers - General
Sector
Healthcare
Market cap
$225B

Company details

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OTH
OI
OIE
PI
TAX
NI
Revenue (Rev)
$48.86B
Cost of goods (CoG)
-$12.41B
Gross profit (GP)
$36.45B
Operating expense (OE)
-$24.72B
Research and development (R&D)
-$11.28B
General and administrative (G&A)
-$12.47B
Other (OTH)
-$975.00M
Operating income (OI)
$11.73B
Other income expense (OIE)
-$254.00M
Pretax income (PI)
$10.90B
Tax (TAX)
-$814.00M
Net income (NI)
$16.18B
Novartis AG
NVS • XNYS • US
$110.56
+16.80 (17.92%)
Stock vs Industry average
  • Industry average

Dividend yield
3.42%
Trailing annual dividend rate
$3.919
Payout ratio
77.24%
EPS
$4.96
Margin profit
33.10%
52 week low
$92.580002
52 week high
$120.889999
50-day simple moving average
$113.92
200-day simple moving average
$113.73
Percent held by insiders
0.00%
Percent held by institutions
6.93%
Dividend yield
3.44%

Change of shares

Cash vs Debt

Comparison of selected companies

 
%
Price change
NVS +18.14%
eps change
NVS +44.14%